Was betrifft es? Warum ist das wichtig?

The study protocol is the core document that:

 

The protocol synopsis is a short summary of the protocol and provides a kind of roadmap or panoramic view of the planned study.

The protocol is often an extensive document. As a result, the synopsis is often presented when applying for grants or seeking other types of support.

 

Swissethics provides a selection of mandatory protocol templates. Which template to use depends on study:

Was muss ich befolgen?

As a SP-INV:

  • Start by selecting the applicable protocol template provided by swissethics. The template ensures compliance with thel formal protocol structure, and provides comprehensive guidance on required protocol content
  • Consider what additional support or expertise must be recruited for the protocol write-up (e.g. a study statistician, quality-, project-, data manager, an experienced study nurse)

 

Aspects to consider when writing your synopsis and study protocol, include to:

Wo kann ich Hilfe anfordern?

Your local Research Support Centre can assist you with experienced staff regarding this topic

  • Basel, Departement Klinische Forschung (DKF), dkf.unibas.ch

  • Lugano, Clinical Trials Unit (CTU-EOC), ctueoc.ch

  • Bern, Department of Clinical Research (DCR), dcr.unibe.ch

  • Geneva, Clinical Research Center (CRC), crc.hug.ch

  • Lausanne, Clinical Research Center (CRC), chuv.ch

  • St. Gallen, Clinical Trials Unit (CTU), h-och.ch

  • Zürich, Clinical Trials Center (CTC), usz.ch

External Links

Swissethics – see in particular

  • Broad selection of protocol templates

References

ICH GCP E6(R3) – see in particular

  • 1.44 Glossary: Protocol definition
  • Appendix B. Clinical trial protocol and protocol amendment(s)

ICH GCP E8(R1) – see in particular guidelines:

  • 2.2 Scientific approach to study planning and implementation

ISO 14155:2020 Medical devices - see in particular sections (access liable to cost)

  • 6.4 Clinical Investigational Plan (CIP)
  • Annex A CIP

Declaration of Helsinki – see in particular principles

  • 21 – 22 Protocol requirements

Swiss Law

ClinO – see in particular articles

  • Art. 19, 20, 49 and 61 Categorisation

ClinO-MD - see in particular

  • Art. 6 Categorisation of clinical trials

HRO – see in particular articles

  • Art. 7 Categorisation
Abkürzungen
  • ClinO - Clinical Trials Ordinance
  • ClinO-MD – Ordinance on Clinical Trials with Medical Device
  • CTU – Clinical Trials Unit
  • EC – Ethics Committee
  • HRO - Human Research Ordinance
  • ICH-GCP – International Council for Harmonisation - Good Clinical Practice
  • IMP– Investigational Medicinal Product
  • ISO – International Organization for Standardization
  • MD – Medical Device
  • SP-INV – Sponsor-Investigator
Concept ↦ Documents ↦ Required Documents ↦ Protocol and Synopsis
Study
Basic

Provides some background knowledge and basic definitions

Basic Monitoring
Concept

Starts with a study idea

Ends after having assessed and evaluated study feasibility

Concept Statistic Methodology
Concept Drug or Device
Development

Starts with confidence that the study is feasible

Ends after having received ethics and regulatory approval

Development Drug or Device
Set-Up

Starts with ethics and regulatory approval

Ends after successful study initiation

Set-Up Ethics and Laws
Set-Up Statistic Methodology
Set-Up Quality and Risk
Set-Up Drug or Device
Conduct

Starts with participant recruitment

Ends after the last participant has completed the last study visit

Conduct Statistic Methodology
Conduct Drug or Device
Completion

Starts with last study visit completed

Ends after study publication and archiving

Completion Drug or Device
Current Path (click to copy): Concept ↦ Documents ↦ Required Documents ↦ Protocol and Synopsis

Please note: the Easy-GCS tool is currently under construction.